Advertisement

The Role of Oncogene Activation in Chemical Carcinogenesis

  • C. S. Cooper
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 94 / 2)

Abstract

Over the past 8 years there has been a revolution in our perception of the ways in which exposure to chemical carcinogens causes cell transformation and tumour induction. The recent exciting advances in this field are rooted in earlier observations that identified genetic material as the probable target during carcinogenesis. Boverii, who in 1914 noted frequent karyotypic abnormalities in tumour cells, is usually credited as the first person to recognise the potential importance of genetic changes in tumour development (reviewed in Strong 1949). More recently, the discovery for particular groups of chemicals of correlations between carcinogenicity and mutagenicity (McCann et al. 1975; McCann and Ames 1976) and between carcinogenicity and the extent of covalent binding of the cancer-causing chemicals to DNA (Brookes and Lawley 1964; Frei et al. 1978) provided important indirect support for the idea that DNA is the critical target during chemical carcinogenesis. This field of endeavour blossomed with the discovery that DNA from lines of chemically transformed cells could be used to transform a line of immortal NIH 3T3 mouse fibroblasts in DNA transfection experiments (Shih1 et al. 1979; Cooper et al. 1980), an observation that provided direct support for the concept that cell transformation may involve the generation of dominantly acting transforming genes (oncogenes) by mutation of particular normal cellular genes (proto-oncogenes). The fruits yielded by the DNA transfection procedure and by other techniques that are now used for detecting activated cellular genes form the subject matter of this chapter.

Keywords

Transforming Gene Oncogene Activation Chemical Carcinogenesis Skin Papilloma Hyperplastic Alveolar Nodule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ames BN, Saul RL (1986) Oxidative DNA damage as related to cancer and ageing. Prog Clin Biol Res 209A:11–26PubMedGoogle Scholar
  2. Balmain A, Pragneil IB (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303:72–74PubMedGoogle Scholar
  3. Balmain A, Ramsden M, Bowden GT, Smith J (1984) Activation of mouse cellular Harvey-nzv in chemically induced benign skin papillomas. Nature 307:658–660PubMedGoogle Scholar
  4. Barbacid M (1987) Ras genes. Ann Rev Biochem 56:779–827PubMedGoogle Scholar
  5. Bargmann CI, Hung M-C, Weinberg RA (1986a) The neu oncogene encodes an epidermal growth factor-related protein. Nature 319:226–230PubMedGoogle Scholar
  6. Bargmann CI, Hung C-M, Weinberg RA (1986b) Multiple independent activations at the neu oncogene by a point mutation altering the transmembrane domain of pi 85. Cell 45:649–657PubMedGoogle Scholar
  7. Bernard O, Cory S, Gerondakis S, Webb E, Adams JM (1983) Sequence of murine and human cellular myc oncogenes and two models of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J 2:2375–2383PubMedGoogle Scholar
  8. Bigger CAH, Sawicki JT, Blake DM, Raymond LG, Dipple A (1983) Products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin. Cancer Res 43:5647–5651PubMedGoogle Scholar
  9. Bizub D, Wood AW, Skalka AM (1986) Mutagenesis of the Ha-ras oncogene in mouse skin tumours induced by poly cyclic aromatic hydrocarbons. Proc Natl Acad Sci USA 83:6048–6052PubMedGoogle Scholar
  10. Blair DG, Oskarsson MK, Wood TG, McClements WL, Fischinger PJ, Vande Woude GF (1981) Activation of the transforming potential of a normal cell sequence: a model for oncogenesis. Science 212:941–943PubMedGoogle Scholar
  11. Blair DG, Cooper CS, Oskarsson MK, Eader LA, Vande Woude GF (1982) New method for detecting cellular transforming genes. Science 218:1122–1125PubMedGoogle Scholar
  12. Blair DG, Wood TG, Woodworth AM, McGeady ML, Oskarsson MK, Propst F, Tainsky MA, Cooper CS, Watson R, Baroudy BM, Vande Woude GF (1984) Properties of the mouse and human mos oncogene loci. In: Vande Woude GF, Levine AJ, Topp WC, Watson JD (eds) Cancer cells: oncogene and viral genes, vol 2. Cold Spring Harbor Laboratory Press, New York, pp 281–289Google Scholar
  13. Bos JL, Verlaan-de Vries M, Jansen AM, Veeneman GH, van Boom JH, van der Eb AJ (1984) Three different mutants in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acid Res 12:9155–9162PubMedGoogle Scholar
  14. Bos JL, Toksoz D, Marshall CJ, Verlaan-de Vries M, Veeneman GH, van der Eb AJ, van Boom JH, Janssen JWG, Steenvoorden ACM (1985) Amino-acid substitutions at codon 13 of the N-ray oncogene in human acute myeloid leukaemia. Nature 315: 726–730PubMedGoogle Scholar
  15. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb A, Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327:293–297PubMedGoogle Scholar
  16. Brookes P, Lawley PD (1964) Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic powder of hydrocarbons and their binding to deoxyribonucleic acid. Nature 202:781–784PubMedGoogle Scholar
  17. Brookes P, Cooper CS, Ellis MV, Warren W, Gardner E, Summerhayes IC (1988) Activated K-ras genes in bladder epithelial cell lines transformed by treatment of primary mouse bladder explant cultures with 7,12-dimethylbenz[a]anthracene. Mol Carcinogenesis 1:82–88Google Scholar
  18. Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S, Balmain A (1986) v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 46:447–456PubMedGoogle Scholar
  19. Canaani E, Dreazen O, Klar A, Rechav G, Ram D, Cohen JB, Givol D (1983) Activation of the c-mos oncogene in mouse plasmocytoma by insertion of an endogenous in- tracisternal A-particle genome. Proc Natl Acad Sci USA 80:7118–7122PubMedGoogle Scholar
  20. Chan AM-L, King HWS, Tempest PR, Deakin EA, Cooper CS, Brookes P (1987) Primary structure of the met protein tyrosine kinase domain. Oncogene 1:229–233PubMedGoogle Scholar
  21. Chan AM-L, King HWS, Deakin EA, Tempest PR, Hilkens J, Kroezen V, Edwards DR, Wills AJ, Brookes P, Cooper CS (1988) Characterisation of the mouse met protoon- cogene. Oncogene 2:593–599PubMedGoogle Scholar
  22. Cohen JB, Unger T, Rechavi G, Canaani E, Givol D (1983) Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature 306:797–799PubMedGoogle Scholar
  23. Cooper CS, Blair DG, Oskarsson MK, Tainsky MA, Eader LA, Vande Woude GF (1984a) Characterization of human transforming genes from chemically transformed teratocarcinomas and pancreatic carcinoma cell lines. Cancer Res 44:1–10PubMedGoogle Scholar
  24. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF (1984b) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29–33PubMedGoogle Scholar
  25. Cooper GM, Okerquist S, Silverman L (1980) Transforming activity of DNA of chemically transformed and normal cells. Nature 284:418–421PubMedGoogle Scholar
  26. Corcoran LM, Adams JM, Dunn AR, Cory S (1984) Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell 37: 113–122PubMedGoogle Scholar
  27. Cory S (1986) Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res 47:189–234PubMedGoogle Scholar
  28. Cowell JK (1981) Chromosome abnormalities associated with salivary gland epithelial cell lines transformed in vitro and in vivo with evidence of a role for genetic imbalance in transformation. Cancer Res 41:1508–1517PubMedGoogle Scholar
  29. Cuypers HT, Selten G, Quint W, Zijlstra M, Robanus-Maandag E, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukaemia virus-induced T-cell lymphomagenesis: integration of provirus in a distinct chromosomal region. Cell 37:141–150PubMedGoogle Scholar
  30. Dandekar S, Sukumar S, Zarbl H, Young LJT, Cardiff RD (1986) Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthraeene-induced mouse mammary tumours. Mol Cell Biol 6:4104–4108PubMedGoogle Scholar
  31. DeLeo AB, Joy G, Appella E, Dubois GC, Law LW, Old LJ (1979) Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci USA 76:2420–2424PubMedGoogle Scholar
  32. Diamond LE, Guerrero I, Pellicer A (1988) Concomitant K- and N-ras gene point mutations in cloncal murine lymphomas. Mol Cell Biol 8:2233–2236PubMedGoogle Scholar
  33. Doniger J, Notario V, DiPaolo JA (1987) Carcinogens with diverse mutagenic activities initiate neoplastic guinea pig cells that acquire the same N-ras point mutation. J Biol Chem 262:3813–3819PubMedGoogle Scholar
  34. Drebin J A, Stern DF, Link VL, Weinberg RA, Greene MI (1984) Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature 312:545–548PubMedGoogle Scholar
  35. Drebin J A, Link VC, Stern DF, Weinberg RA, Green MI (1985) Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41:695–706Google Scholar
  36. Eva A, Aaronson SA (1983) Frequent activation of c-kis as a transforming gene in fibrosarcomas induced by methyleholanthrene. Science 220:955–95PubMedGoogle Scholar
  37. Eva A, Trimmer W (1986) High frequency of c-K-ras activation in 3-methylcholanthrene-induced mouse thymomas. Carcinogenesis 7:1931–1933PubMedGoogle Scholar
  38. Evans CH, DiPaolo J A (1975) Neoplastic transformation of guinea pig fetal cells in culture induced by chemical carcinogens. Cancer Res 35:1035–1044PubMedGoogle Scholar
  39. Fennell TR, Wiseman RW, Miller J A, Miller EC (1985) Major role of hepatic sulfotrans- ferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of l’-hydroxy-2’, 3’-dehydroestragole in infant male C57BL/6Jx- CSH/HeJFi mice. Cancer Res 45:5310–5320PubMedGoogle Scholar
  40. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327:298–303PubMedGoogle Scholar
  41. Foulds L (1969) Neoplastic development, vol 1. Academic, LondonGoogle Scholar
  42. Fox TR, Watanabe PG (1985) Detection of a cellular oncogene in spontaneous liver tumours of B6C3F1 mice. Science 228:596–597PubMedGoogle Scholar
  43. Frei JV (1980) Methylnitrosourea induction of thymomas in AKR mice requires one or two “hits” only. Carcinogenesis 1:721–723PubMedGoogle Scholar
  44. Frei JV, Lawley PD (1980) Thymomas induced by simple alkylating agents in C57BL/Cbi mice: kinetics of the dose response. JNCI 64:845–856PubMedGoogle Scholar
  45. Frei JV, Swenson DH, Warren W, Lawley PD (1978) Alkylation of DNA in vivo in various organs of C57BL mice by the carcinogens iV-methyl-iV-nitrosourea and ethyl- methanesulphonate in relation to induction of thymic lymphomas: some applications of high-pressure liquid chromatography. Biochem J 174:1031–1044PubMedGoogle Scholar
  46. Fujita J, Srivastava SK, Kraus MH, Rhim JS, Tronick SR, Aaronson SA (1985) Frequency of molecular alterations affecting ras protooncogene in human urinary tract tumour. Proc Natl Acad Sci USA 82:3849–3853PubMedGoogle Scholar
  47. Garte SJ, Hood AT, Hochwalt AE, D’Eustachio P, Snyder CA, Segal A, Albert RE (1985) Carcinogen specificity in the activation of transforming genes by direct-acting alkylating agents. Carcinogenesis 6:1709–1712PubMedGoogle Scholar
  48. Gattoni-Celli S, Hsiao WW-L, Weinstein IB (1983) Rearrangement of c-mos locus in MOPC21 murine myeloma cell line and its persistence in hybridomas. Nature 306:795–796PubMedGoogle Scholar
  49. Guerrero I, Pellicer A (1987) Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat Res 135:293–308Google Scholar
  50. Guerrero I, Calzada P, Mayer A, Pellicer A (1984a) A molecular approach to leukaemogenesis: mouse lymphomas contain an activated c-ras oncogene. Proc Acad Natl Sci USA 81:202–205Google Scholar
  51. Guerrero I, Villasante A, D’Eustachio P, Pellicer A (1984b) Isolation, characterization and chromosomal assignment of mouse N-ras gene from carcinogen-induced thymic lymphoma. Science 225:1041–1043PubMedGoogle Scholar
  52. Guerrero I, Villasante A, Diamond L, Berman JW, Newcomb EW, Steinberg JJ, Lake R, Pellicer A (1986) Oncogene activation and surface markers in mouse lymphomas induced by radiation and nitrosomethylurea. Leukaemia Res 10:851–858Google Scholar
  53. Gullino PM, Pettigrew HM, Grantham FH (1975) iV-Nitrosomethylurea as a mammary gland carcinogen in rats. JNCI 54:401–409PubMedGoogle Scholar
  54. Hawley RG, Shulman MJ, Murialdo H, Gibson DM, Hozumi N (1982) Mutant im- munoglobin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci USA 79:7425–7429PubMedGoogle Scholar
  55. Hecker E, Fusenig NE, Kinz W, Marks F, Thielmann HW (eds) (1982) Carcinogenesis, vol 7. Raven, New YorkGoogle Scholar
  56. Huggins C, Grand LC, Brillantes FP (1961) Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 189:204–207PubMedGoogle Scholar
  57. Ireland CM, Cooper CS, Marshall CJ, Hebert E, Phillips DH (1988) Activating mutations in human c-Ha-ras-1 gene induced by reactive derivatives of safrole and the glutamic acid pyrolysate, Glu-P-3. Mutagenesis 3:429–435PubMedGoogle Scholar
  58. Jenkins JR, Rudge K, Chumakov P, Currie GA (1985) The cellular oncogene p53 can be activated by mutagenesis. Nature 317:816–818PubMedGoogle Scholar
  59. Klein G (1987) The approaching era of the tumour suppressor genes. Science 238: 1539–1545PubMedGoogle Scholar
  60. Konopka JB, Watanabe SM, Witte ON (1984) An alteration of the human c-abl protein in K562 leukaemia cells unmasks associated tyrosine kinase activity. Cell 37:1035–1045PubMedGoogle Scholar
  61. Kuff EL, Feenstra A, Lueders K, Rechavi G, Givol D, Canaani E (1983) Homology between an endogenous viral LTR and sequence inserted in an activated cellular oncogene. Nature 302:547–548PubMedGoogle Scholar
  62. Laerum OD, Rajewsky MF (1975) Neoplastic transformation of fetal rat brain cells in culture after exposure to ethyl nitrosourea in vivo. JNCI 55:1177–1184PubMedGoogle Scholar
  63. Lai C-C, Miller JA, Miller EC, Liem A (1985) AT-Sulfoxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of iVr-hydroxy-2-acetylamino- fluorene in the liver of infant male C57BL/6J x C3H/HeJF1 (B6C3F!) mice. Carcinogenesis 6:1037–1045PubMedGoogle Scholar
  64. Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596–602PubMedGoogle Scholar
  65. Lane DP (1987) p53 in Paris, an oncogene comes of age. Oncogene 1:241–242PubMedGoogle Scholar
  66. Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261–263PubMedGoogle Scholar
  67. Lantos PL (1986) Development of nitrosourea-induced brain tumours with a special note on changes occurring during latency. Chem Toxicol 24:121–127Google Scholar
  68. Lawley PD (1976) Comparison of alkylating agents and radiation carcinogenesis: some aspects of the possible involvement of effects of DNA. In: Yunkas JM, Tennant RW, Regan JD (eds) Biology of radiation carcinogenesis. Raven, New York, pp 165–174Google Scholar
  69. Leon J, Guerrero I, Pellicer A (1987) Differential expression of the ras gene family in mice. Mol Cell Biol 7:1535–1540PubMedGoogle Scholar
  70. Leon J, Kamino H, Steinberg JJ, Pellicer A (1988) H-ras activation in benign and self- regressing skin tumours (keratoacanthomas) in both humans and on animal model system. Mol Cell Biol 8:786–793PubMedGoogle Scholar
  71. Lewis SE, Johnson FM, Skow LC, Popp D, Barnett LB, Popp RA (1985) A mutation in the /?-globin gene detected in the progeny of a female mouse treated with ethyl- nitrosourea. Proc Natl Acad Sci USA 82:5829–5831PubMedGoogle Scholar
  72. Marshall CJ, Vousden KH, Phillips DH (1984) Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo[a]pyrene diol-epoxide. Nature 310:586–589PubMedGoogle Scholar
  73. Martin-Zanca D, Hughes SH, Barbacid M (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein kinase sequences. Nature 319:743–748PubMedGoogle Scholar
  74. McCann J, Ames BN (1976) Detection of carcinogens as mutagens in the Salmonella!microsome test: assay of 300 chemicals: Discussion. Proc Natl Acad Sci USA 73:950–954PubMedGoogle Scholar
  75. McCann J, Choie E, Yamasaki E, Ames BN (1975) Detection of carcinogens as mutagens in the /microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA 72:5135–5139PubMedGoogle Scholar
  76. McMahon G, Hanson L, Lee J-J, Wogan GN (1986) Identification of an activated c-Ki- ras oncogene in rat liver tumours induced by aflatoxin Bt. Proc Natl Acad Sci USA 83:9418–9422PubMedGoogle Scholar
  77. Nordling CO (1953) A new theory on the cancer-inducing mechanism. Br J Cancer 7:68–72PubMedGoogle Scholar
  78. Ochai M, Nagao M, Tahira T, Ishikawa F, Hayash K, Ohgaki H, Terada M, Tsuchida N, Sugimura T (1985) Activation of K-ras and oncogenes other than ras family in rat fibrosarcoma induced by 1,8-dinitropyrene. Cancer Lett 29:119–125Google Scholar
  79. Padhy LC, Shih C, Cowing D, Finkelstein R, Weinberg RA (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28:865–871PubMedGoogle Scholar
  80. Parada LF, Weinberg RA (1983) Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene. Mol Cell Biol 3:2298–2301PubMedGoogle Scholar
  81. Park M, Dean M, Cooper CS, Schmidt M, O’Brien SJ, Blair DG, Vande Woude GF (1986) Mechanism of met oncogene activation. Cell 45:895–904PubMedGoogle Scholar
  82. Park M, Dean M, Karl K, Braun MJ, Gonda MA, Vande Woude GF (1987) Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sei USA 84:6379–6383Google Scholar
  83. Pelling JC, Neodes R, Strawhecker J (1988) Epidermal papillomas and carcinomas in-duced in uninitiated mouse skin by tumour promoters alone containt point mutations in the 61st codon of the Ha-ras oncogene. Carcinogenesis 9:665–667PubMedGoogle Scholar
  84. Popp RA, Baliff EG, Skow LC, Johnson FM, Lewis SE (1983) Analysis of a mouse a-globin gene mutation induced by ethylnitrosourea. Genetics 105:157–167PubMedGoogle Scholar
  85. Potter M (1984) Genetics of susceptibility to plasmocytoma development in BALB/c mice. Cancer Surv 3:247–264Google Scholar
  86. Pulciani B, Santos E, Lauver AV, Long LK, Aaronson SA, Barbacid M (1982) Oncogenes in solid human tumours. Nature 300:539–542PubMedGoogle Scholar
  87. Quintanilla M, Brown K, Ramsden M, Balmain A (1986) Carcinogen-specific mutation and amplification of H-ras during mouse skin carcinogenesis. Nature 322:78–80PubMedGoogle Scholar
  88. Rajewsky MF (1983) Structural modifications and repair of DNA in neuro-oncogenesis by TV-ethyl-iV-nitrosourea. Recent Results Cancer Res 84:63–75PubMedGoogle Scholar
  89. Rechavi G, Givol D, Canaani E (1982) Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature 300:607–610PubMedGoogle Scholar
  90. Reddy EP, Reynolds PK, Santos E, Barbacid M (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300:149–152PubMedGoogle Scholar
  91. Reynolds SH, Stowers SJ, Maronpot RR, Anderson MW, Aaronson SA (1986) Detection and identification of activated oncogenes, in spontaneously occurring benign and malignant hepatocellular tumours of the B6C3F1 mouse. Proc Natl Acad Sei USA 83:33–37Google Scholar
  92. Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW (1987) Activated oncogenes in B6C3F1 mouse liver tumours: implications for risk assessment. Science 237:1309–1316PubMedGoogle Scholar
  93. Rhim JS, Kin CM, Arnstein OP, Huebner RJ, Weisburger EK, Nelson-Rees WA (1975a) Transformation of human osteosarcoma cells by a chemical carcinogen. JNCI 55: 1291–1294PubMedGoogle Scholar
  94. Rhim JS, Park DK, Arnstein P, Huebner RJ, Weisburger EK (1975b) Transformation of human cells in culture by N-methyl-N’-nitro-iV-nitrosoguanidine. Nature 256: 751–753PubMedGoogle Scholar
  95. Rhim JS, Fujita J, Park JB (1987) Activation of H-ras oncogene in 3-methylcholanthrene-transformed human cell line. Carcinogenesis 8:1165–1167PubMedGoogle Scholar
  96. Richardson KK, Richardson FC, Crosby RM, Swenberg JA, Stopek TR (1987) DNA base charges and alkylation following in vivo exposure of Escherichia coli to JV-methyl-iV- nitrosourea or iV-ethyl-JV-nitrosourea. Proc Natl Acad Sei USA 84:344–348Google Scholar
  97. Roscoe JP, Claisse PJ (1976) A sequential in vivo — in vitro study of carcinogenesis induced in the rat brain by ethylnitrosourea. Nature 262:314–316PubMedGoogle Scholar
  98. Roscoe JP, Claisse PJ (1978) Analysis of iV-ethyl-N-nitrosourea-induced brain carcinogenesis by sequential culturing during the latent period. I. Morphology and tumorigenicity of the cultured cells and their growth in agar. JNCI 61:381–386PubMedGoogle Scholar
  99. Rotter V (1983) p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumour cells. Proc Natl Acad Sei USA 80:2613–2617Google Scholar
  100. Sawey MS, Hood AT, Burns FJ, Garte SV (1987) Activation of c-myc and c-K-ras on-cogenes in primary rat tumours induced by ionizing radiation. Mol Cell Biol 7:932–935PubMedGoogle Scholar
  101. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Green MI, Weinberg RA (1984) The neu oncogene: as er&B-related gene encoding a 185000-M, tumour antigen. Nature 312:512–516Google Scholar
  102. Schechter AL, Hung M-C, Vaidyanathan L, Weinberg RA, Yang-Feng T, Francke U, Ullrich A, Coussens L (1985) The neu gene: an er&B-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229:976–978PubMedGoogle Scholar
  103. Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD (1984) Biological properties of human c-Ha-ras-l genes mutated at codon 12. Nature 312:71–75PubMedGoogle Scholar
  104. Seltan G, Cuypers HT, Boelens W, Robanus-Maandog E, Verbeek J, Domen J, van- Beveren C, Berns A (1986) The primary structure of the putative oncogene pirn-1 shows extensive homology with protein kinases. Cell 46:603–611Google Scholar
  105. Shih C, Shilo B-Z, Goldfarb MP, Dannenberg A, Weinberg RA (1979) Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA 76:5714–5718PubMedGoogle Scholar
  106. Shih C, Padhy LC, Murray M, Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261–264PubMedGoogle Scholar
  107. Sinha D, Dao TL (1975) Site of origin of mammary tumours induced by 7,12-dimethyl-benz[#]anthracene in the rat. JNCI 54:1007–1008PubMedGoogle Scholar
  108. Stowers SY, Glover PL, Reynolds SH, Boone LR, Maronpot RR, Anderson MW (1987) Activation of the K-ras protooncogene in lung tumours from rats and mice chronically exposed to tetranitromethane. Cancer Res 47:3212–3219PubMedGoogle Scholar
  109. Stowers SJ, Wiseman RW, Ward JM, Miller EC, Miller JA, Anderson MW, Eva A (1988) Detection of activated proto-oncogenes in JV-nirosodiethylamine-induced liver tumours: a comparison between B6C3F! mice and Fischer 344 rats. Carcinogenesis 9:271–276PubMedGoogle Scholar
  110. Strong LC (1949) The induction of mutations by a carcinogen. Br J Cancer 3:97–108PubMedGoogle Scholar
  111. Sukumar S, Notario J, Martin-Zanca D, Barbacid M (1983) Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 306:658–661PubMedGoogle Scholar
  112. Sukumar S, Pulciani S, Doniger J, DiPaolo J A, Evans CH, Zbar B, Barbacid M (1984) A transforming ras gene in tumorigenic guinea pig cell lines initiated by diverse chemical carcinogens. Science 223:1197–1199PubMedGoogle Scholar
  113. Sukumar S, Perantoni A, Reed C, Rice JM, Wenk ML (1986) Activated K-ras and N-ras oncogenes in primary renal mesenchymal tumours induced in F344 rats by methyl(methoxymethanol)nitrosamine. Mol Cell Biol 6:2716–2720PubMedGoogle Scholar
  114. Summerhayes IC, Franks LM (1979) Effect of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. JNCI 62:1017–1023PubMedGoogle Scholar
  115. Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH (1982) Mechanism of activation of a human oncogene. Nature 300:143–149PubMedGoogle Scholar
  116. Tahira T, Hayashi K, Ochiai M, Tsuchida N, Nagao M, Sugimura T (1986) Structure of the c-Ki-ras gene in a rat fibrosarcoma induced by 1,8-dinitropyrene. Mol Cell Biol 6:1349–1351PubMedGoogle Scholar
  117. Tempest PR, Reeves BR, Spurr NK, Ranee AJ, Chan AM-L, Brookes P (1986) Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement. Carcinogenesis 7:2051–2057PubMedGoogle Scholar
  118. Tempest PR, Sratton MR, Cooper CS (1988) Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br J Cancer (in press)Google Scholar
  119. Topal MD, Eadie JS, Conrad M (1986) 06-Methy1lguanine mutation and repair is nonuniform. J Biol Chem 261:9879–9885PubMedGoogle Scholar
  120. Vousden KH, Bos JL, Marshall CJ, Phillips DH (1986) Mutations activating human c-Ha- ras-1 protooncogene (HRASI) induced by chemical carcinogens and depurination. Proc Natl Acad Sci USA 83:1222–1226PubMedGoogle Scholar
  121. Warren W, Lawley PD, Gardner E, Harris G, Ball JK, Cooper CS (1987) Induction of thymomas by jV-methyl-jV-nitrosourea in AKR mice: interaction between the chemical carcinogen and endogenous murine leukaemia viruses. Carcinogenesis 8:163–172PubMedGoogle Scholar
  122. Wiseman RW, Stowers SV, Miller EC, Anderson MW, Miller J A (1986) Activating mutations of the c-Ha-ras protooncogenes in chemically induced hepatomas of the male B6C3F1 mouse. Proc Natl Acad Sci USA 83:5825–5829PubMedGoogle Scholar
  123. Wong DT (1987) Amplification of the c-erb B1 oncogene in chemically induced oral carcinomas. Carcinogenesis 8:1963–1965PubMedGoogle Scholar
  124. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315:382–385PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • C. S. Cooper

There are no affiliations available

Personalised recommendations